What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News A Vall d’Hebron study relates the impact of obesity to cognitive impairment The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention. News Vall d’Hebron participates in RESPONSE, a global phase III clinical trial for the treatment of primary biliary cholangitis The innovative oral drug could provide a new therapeutic option for people with PBC who have not obtained the recommended therapeutic outcome or who do not tolerate first line therapy and cannot continue their treatment. News Recruitment of volunteers starts for the Phase III clinical trial of the HIPRA COVID-19 vaccine The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy. News Celebrem la II Jornada d’Actualització en Infeccions de Transmissió Sexual en el context de la infecció pel VIH L'objectiu de la jornada és revisar les Infeccions de Transmissió Sexual (ITS) amb major impacte clínic i de salut pública amb un enfocament teòric-pràctic a través de casos clínics interactius que facilitin la discussió i l’aprenentatge. News The story ‘We love you, little brave!’ donates its benefits to the Pediatric Cardiology Service of Vall d'Hebron Anna Gutiérrez's son was born in November 2019 with a congenital heart disease, for which he was operated on when he was five days old. Experience that inspired her to write the story ‘We love you, little brave!’. News Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder The PORTICO study will evaluate the efficacy and safety of vafidemstat in Borderline Personality Disorder patients. Activities From genome to precision medicine in pediatric movement disorders Activities From genome to precision medicine in pediatric movement disorders Activities Reunión anual de la Sociedad Española de Cardiología. Sección de Cardiología Geriátrica Activities II Jornada Trastorno Espectro Alcohólico Fetal Pagination Previous page ‹‹ Page 128 Next page ››